Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Upcoming event

Latest presentation

Latest Report

November 4, 2021

Interim report Q3, 2021

Calendar and upcoming reports

November 24-25, 2021

Nordea Virtual Innovation Seminar 2021

November 29, 2021

ABG Nordic Seminar

February 17, 2022

Year-end-report

April 26, 2022

Interim report January - March

May 10, 2022

Annual General Meeting

August 19, 2022

Half-year report January - June

November 8, 2022

Interim report January - September

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com